BioStock: Cereno listed on Nasdaq First North Growth Market

Cereno Scientific has begun trading its shares on Nasdaq First North Growth market. This is a key step for the Swedish biotech, whose aim is to bring novel treatments to those suffering from cardiovascular disease. BioStock talked to Cereno’s CEO Sten R Sörensen to learn more about the new opportunities that the listing change brings for the company.

Read the interview with Sten R Sörensen at biostock.se:

Cereno listed on Nasdaq First North Growth Market - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/